ClinicalTrials.gg
RecruitingNCT07943338SATISCHOLUpdated Nov 17, 2026

Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital

An observational study in Cholelithiasis, Cholecystitis and Gallbladder, sponsored by University Hospital, Limoges. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University Hospital, Limoges · Observational

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.

The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).

A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.

Read the detailed description

Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.

Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.

Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.

Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.

This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.

Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.

Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.

Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.

Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.

The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.

02

Conditions studied

  • Cholelithiasis
  • Cholecystitis
  • Gallbladder
  • Postoperative Pain
  • Quality of Care

Keywords

  • Cholecystectomy
  • Pain Management
  • Postoperative Pain
  • Visual Analogue Scale
  • Clavien-Dindo Classification
  • Patient-Reported Outcome Measures
  • PROMs
  • Patient-Reported Experience Measures PREMs
  • GIQLI
  • EQ-5D-5L
  • Quality of Life
03

In context

Cholelithiasis

190 studies on the registry are indexed under Cholelithiasis; 42 are open to participants now.

This study's planned enrollment of 70 is below the median of 196 across 51 observational studies indexed under Cholelithiasis.

Browse Cholelithiasis studies →

Lead sponsor

University Hospital, Limoges is the lead sponsor of 265 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Patients undergoing elective cholecystectomy.
  • Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
  • Patients able to complete questionnaires independently or with the assistance of a caregiver.
  • Patients covered by a health insurance scheme.
  • Patients who have not objected to participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing emergency surgery.
  • Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
  • Patients with a history of chronic gastrointestinal disease.
  • Patients with known gallbladder cancer.
  • Patients scheduled for open laparotomy.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients undergoing elective cholecystectomy

    Adult patients undergoing elective cholecystectomy at Limoges University Hospital

06

What researchers measure

Primary outcomes

  1. Proportion of patients with a visual analogue scale (VAS) pain

    Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.

    Time frame: From two hours after surgery to four weeks postoperatively.

Secondary outcomes

  1. Proportion of patients with a VAS pain score

    Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy.

    Time frame: Two hours after surgery.

  2. Proportion of patients experiencing early postoperative complications

    Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification.

    Time frame: Up to four weeks after surgery.

  3. Description of intraoperative pain management techniques

    Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable.

    Time frame: During surgery

  4. Change in the total Gastrointestinal Quality of Life Index (GIQLI) score

    Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2)

    Time frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

  5. Change in the EQ-5D-5L visual analogue scale (VAS)

    Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2).

    Time frame: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).

  6. Description of patient-reported experience using the study-specific PREMS questionnaire

    Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item.

    Time frame: Postoperative assessment at 3 to 6 weeks (T2)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2027, 24 months after the start.

Of 20 observational studies under Cholelithiasis, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 191. This study's planned 24 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 17, 2026
StartActual
Jun 13, 2025
Primary completionEst.
Jun 13, 2027
CompletionEst.
Jun 13, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943338
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jun 13, 2025
Primary completion
Jun 13, 2027 (estimated)
Completion
Jun 13, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Niki CHRISTOU, Professor
Contact
niki.christou@chu-limoges.fr
05 55 05 55 55
Niki CHRISTOU, Professor
principal investigator · University Hospital, Limoges

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion